erlotinib hydrochloride has been researched along with hyaluronoglucosaminidase in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (hyaluronoglucosaminidase) | Trials (hyaluronoglucosaminidase) | Recent Studies (post-2010) (hyaluronoglucosaminidase) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 8,858 | 280 | 1,390 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chariot, A; Shostak, K | 1 |
1 review(s) available for erlotinib hydrochloride and hyaluronoglucosaminidase
| Article | Year |
|---|---|
EGFR and NF-κB: partners in cancer.
Topics: Animals; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Hyaluronoglucosaminidase; Neoplasms; NF-kappa B; Protein Kinase Inhibitors; Proteins; Quinazolines; Signal Transduction | 2015 |